Novartis AG
126.60 CHF-0.18 (-0.14%)
ListedCHF247.9BHealthcareDrug Manufacturers - General75,267 employees
Novartis AG is a Swiss multinational pharmaceutical company headquartered in Basel, specializing in innovative medicines across multiple therapeutic areas including cardiovascular, immunology, neuroscience, oncology, and renal and metabolic diseases. The company operates through two primary divisions: Innovative Medicines, which develops and markets cutting-edge pharmaceutical treatments, and Sandoz, a leading generics business. Novartis medicines reach millions of patients worldwide through a diverse portfolio of prescription drugs and specialty pharmaceuticals. The company serves patients, healthcare professionals, and societies globally, combining research and development capabilities with advanced manufacturing and distribution infrastructure. Novartis maintains a strong presence across major markets, with research facilities and operations in multiple countries. The company's commitment centers on developing treatments for serious and life-threatening conditions while ensuring broad patient access to medical innovations through its global network.
Total Cash (MRQ)
6.25B
Total Debt (MRQ)
40.20B
Current Ratio (MRQ)
0.86
Book Value / Share
16.25